The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Real world hospital costs associated with nab-paclitaxel plus gemcitabine (nab-P+G) and FOLFIRINOX (FFX) as first line (1L) treatment (tx) for metastatic pancreatic adenocarcinoma (MPAC).

George P.  Kim

Honoraria - Celgene

Consulting or Advisory Role - Celgene

Speakers' Bureau - Celgene

Travel, Accommodations, Expenses - Celgene

Monika  Parisi

Employment - Celgene

Stock and Other Ownership Interests  - Celgene

Manish  Patel

Employment - Celgene

Stock and Other Ownership Interests  - Celgene

Kathy  Belk

Employment - MedAssets